This is FDA approved only to increase pain free light exposure in adults with erythropoietic protoporphyria, a rare photosensitivity disorder 3
The literature is fairly consistent on this point across the conditions Ive listed out above
H tr lm trng da, gip da u mu, sng khe, cng trn sc sng
GLP-3, as a triple agonist targeting GLP-1, GIP, and GCG receptors, holds significant promise as a research compound in the investigation of type 2 diabetesnot only through its observed influence on glycemic parameters but also via its substantial impact on weight reduction
Alliin [( R C S S )- S -allyl-L-cysteine sulfoxide] was synthesized and purified according to previously reported methods (Yu et al., 1994
Notably, BBR metabolites demonstrate pharmacological activity comparable to or exceeding that of the parent compound